Document:

Form of License Agreement

 EXHIBIT 10.32 
  
 LICENSE AGREEMENT 
  
 AGREEMENT dated as of                      (the
“Effective Date”) by and among JEFFERIES FINANCIAL PRODUCTS, LLC (“Jefferies”), a Delaware limited liability company having an office at One Station Place, 3N, Stamford, CT 06902, REUTERS AMERICA LLC (“Reuters”), a
Delaware limited liability company having an office at Three Times Square, New York, NY 10036, The Frontier Fund (the “Fund”), a statutory trust formed under the laws of Delaware, and Equinox Fund Management, LLC, a Delaware limited
liability company with its principal office at 1660 Lincoln Street, Suite 100, Denver, CO 80264 (the “Managing Owner”) (the Fund and the Managing Owner collectively “Licensee”). 
  
 WHEREAS, Jefferies and Reuters (collectively “Licensors”) have
entered into a joint marketing agreement pursuant to which they have agreed to jointly promote and market the Reuters/Jefferies CRB Index (the “Joint Marketing Agreement”); 
  
 WHEREAS, one or both of the Licensors, individually, jointly, together with affiliates or agents, as applicable, compiles,
calculates, maintains and owns rights in and to the Reuters/Jefferies CRB Index, and to the proprietary data contained therein (individually and collectively referred to as the “Reuters/Jefferies CRB Index”); and 
  
 WHEREAS, Licensee or its affiliates wishes to use the Reuters/Jefferies CRB
Index as the basis of the product(s) described in Exhibit A hereto (the “Product(s)”); and 
  
 WHEREAS, Licensee wishes to use Jefferies’ and/or Reuters’ names and the Reuters/Jefferies CRB Index name (together the “Marks”) in
connection with the issuance, marketing and/or promotion of the Product(s) under applicable law, rules and regulations in order to indicate that Licensors are the source of the Reuters/Jefferies CRB Index; and 
  
 WHEREAS, Licensors wish to license to Licensee the use of the
Reuters/Jefferies CRB Index and the Marks in connection with the Product(s) all in accordance with the terms and conditions hereinafter set forth; 
  
 NOW, THEREFORE, the parties hereto agree as follows: 
  
 1. Grant and Scope of License. Subject to the terms and conditions of this Agreement, Licensors hereby grant Licensee a non-exclusive, non-transferable,
worldwide, limited license, with no right to sublicense, (i) to reproduce, distribute and display publicly the Reuters/Jefferies CRB Index as a component of the Product(s) described in Exhibit A to be issued, written and/or sold by Licensee;
and (ii) to use and refer to the Marks in connection with the marketing and promotion of such Product(s) and in connection with making such disclosure about the Product(s) as Licensee deems necessary or desirable under any applicable law, rules
or regulations, but, in each case, only to the extent necessary to indicate the source of the Reuters/Jefferies CRB Index and subject to Section 4. It is expressly agreed and understood by Licensee that no rights to use the Reuters/Jefferies
CRB Index or the Marks are granted hereunder other than those specifically described and expressly granted herein. 
  
 2. Term and Termination.  
  
 (a) This Agreement shall commence on the Effective Date and shall continue in effect for three (3) years (“Initial Term”), after which it
shall automatically renew for successive one-year periods (each a “Renewal Term” and together with the Initial Term the “Term”) unless and until (i) Licensors or Licensee terminate this Agreement at the expiration of the
Initial Term or any Renewal Term by giving at least ninety (90) days’ prior written notice to the other parties, or (ii) terminated as set forth below; 
  
 (b) Licensors shall have the right to immediately terminate this Agreement in the event of any breach or threatened breach
of this Agreement by Licensee if: (a) the breach or threatened breach has remained uncured for thirty (30) days following Licensee’s receipt of Licensor’s written notice of such claim, or (b) the breach or threatened breach
is not susceptible to cure; 
  
 (c) Licensors shall have the right
to terminate this Agreement upon termination of the Joint Marketing Agreement; and 
  
 (d) Licensors shall have the right to terminate this Agreement if Licensors determine in their joint discretion to suspend offering the Reuters/Jefferies CRB Index to licensees in general. 
  
 3. License Fees. 
  
 (a) As consideration for the license granted under the Agreement with respect to the Product(s) listed in Exhibit A,
Licensee shall pay to Reuters the fees (“License Fees”) as set forth on Exhibit B hereto. Licensee shall pay the License Fees within ten business days after the end of the calendar quarter to which the License Fees relate. All
amounts shall be paid in cash and shall be 

 
non-refundable. All amounts stated are net of any withholding taxes, such that the amounts due and payable to Reuters under this Agreement, after any
applicable deduction or withholding for or on account of any present or future taxes, levies, imposts, duties, fees, assessments or other charges of whatever nature now or hereafter imposed, will not be less than the amounts set forth on Exhibit B.

  
 (b) Licensee shall deliver to Licensors, within ten business
days after each calendar quarter during the Term, a written report detailing, in respect of the closing date of such quarter, a list of each Product described in Exhibit A and the net asset value of such Product. 
  
 (c) Licensors shall have the right, which may be exercised themselves or
through their agents, to audit on a confidential basis the relevant books and records of Licensee to confirm the accuracy of any one or more calculations of License Fees. Licensors shall bear their own costs of any such audit unless it is determined
that Licensors have been underpaid by 5% or more with respect to the payments being audited, in which case Licensors’ costs of such audit shall be paid by Licensee. 
  
 (d) Licensee shall be responsible for all costs associated with the receipt of the Reuters/Jefferies CRB Index. 

 
 4. Informational Materials Review. 
  
 (a) Licensee shall use its best efforts to protect the goodwill and
reputation of the Reuters/Jefferies CRB Index and of the Marks in connection with its use of the Marks under this Agreement. For the avoidance of doubt, Licensee is not responsible for sending cease and desist letters and/or filing suits to enforce
the Marks; however, Licensee is responsible for notifying Licensors promptly if Licensee becomes aware of any infringement or threatened infringement. 
  
 (b) Licensee shall submit to Licensors for their review and approval all prospectuses, registration statements, advertisements, brochures and promotional
and any other similar informational materials (including documents required to be filed with governmental or regulatory agencies) relating to the Product(s) and that in any way use or refer to Licensors or the Reuters/Jefferies CRB Index (the
“Informational Materials”). Each applicable Licensor’s approval shall be required with respect to the use of and description of a Licensor, and Licensors’ approval shall be required with respect to the use of and description of
the Reuters/Jefferies CRB Index. Approval by Licensor(s) hereunder shall not be unreasonably withheld or delayed. Once Informational Materials have been approved by Licensor(s), subsequent Informational Materials that do not alter the use or
description of Licensors and the Reuters/Jefferies CRB Index need not be submitted for review and approval by Licensors. 
  
 (c) In each item of Informational Material, Licensee shall use only the full name of the Reuters/Jefferies CRB Index, and shall not use any abbreviation
therefor. 
  
 5. Proprietary Rights. 
  
 (a) Licensee acknowledges that the Reuters/Jefferies CRB Index is selected,
coordinated, arranged and prepared by Licensors through the application of methods and standards of judgment used and developed through the expenditure of considerable work, time and money by Licensors. Licensee also acknowledges that, as between
Licensee and Licensors, the Marks are the exclusive property of Reuters, Jefferies and/or their respective subsidiaries or affiliates, as the case may be, that such parties have and retain all proprietary rights therein (including, but not limited
to, trademarks and copyrights) and that the Reuters/Jefferies CRB Index and its compilation and composition and changes therein are in the control and sole discretion of Licensors. 
  
 (b) Licensors reserve all rights with respect to the Reuters/Jefferies CRB Index and the Marks except those expressly
licensed to Licensee hereunder. 
  
 (c) The following notice will
appear at the foot of any list or table which reproduces in whole or substantial part the Reuters/Jefferies CRB Index: “Copyright 200[ ]. Reuters America LLC and/or Jefferies Financial Products, LLC or their affiliates. Used with
permission.” 
  
 6. Warranties; Disclaimers; Indemnification.

  
 (a) Licensors represent and warrant that as of the date hereof
Licensors or their affiliates own all right, title and interest in, or, to the extent not owned, have all necessary rights to use, the Marks and to grant the license hereunder. 
  
 (b) Licensee agrees expressly to be bound itself by and furthermore to include all of the following disclaimers and
limitations in its Informational Materials and any contract(s) relating to the Product(s) and upon request to furnish a copy (copies) thereof to Licensors: 
  
 “THE PRODUCT(S) IS NOT SPONSORED, ENDORSED, SOLD OR PROMOTED BY REUTERS AMERICA LLC (“REUTERS”), JEFFERIES FINANCIAL PRODUCTS, LLC
(“JEFFERIES”) OR ANY OF THEIR SUBSIDIARIES OR AFFILIATES 

 
(COLLECTIVELY THE “LICENSORS”). LICENSORS MAKE NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO THE OWNERS OF THE PRODUCT(S) OR ANY MEMBER OF
THE PUBLIC REGARDING THE ADVISABILITY OF INVESTING IN SECURITIES OR COMMODITIES GENERALLY OR IN THE PRODUCT(S) PARTICULARLY OR THE ABILITY OF THE REUTERS/JEFFERIES CRB INDEX TO TRACK GENERAL COMMODITY MARKET PERFORMANCE. LICENSORS’ ONLY
RELATIONSHIP TO [LICENSEE NAME] (“LICENSEE”) IS THE LICENSING OF THE REUTERS/JEFFERIES CRB INDEX, WHICH IS DETERMINED, COMPOSED AND CALCULATED BY LICENSORS WITHOUT REGARD TO THE LICENSEE OR THE PRODUCT(S). LICENSORS HAVE NO OBLIGATION TO
TAKE THE NEEDS OF THE LICENSEE OR THE OWNERS OF THE PRODUCT(S) INTO CONSIDERATION IN DETERMINING, COMPOSING OR CALCULATING THE REUTERS/JEFFERIES CRB INDEX. LICENSORS ARE NOT RESPONSIBLE FOR AND HAVE NOT PARTICIPATED IN THE DETERMINATION OF THE
TIMING OF, PRICES AT, OR QUANTITIES OF THE PRODUCT(S) TO BE ISSUED OR IN THE DETERMINATION OR CALCULATION OF THE EQUATION BY WHICH THE PRODUCT(S) IS TO BE CONVERTED INTO CASH. LICENSORS HAVE NO OBLIGATION OR LIABILITY IN CONNECTION WITH THE
ADMINISTRATION, MARKETING OR TRADING OF THE PRODUCT(S). 
  
 LICENSORS AND THEIR AFFILIATES AND THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES AND AGENTS MAY BUY OR SELL SECURITIES OR COMMODITIES MENTIONED OR CONTEMPLATED HEREIN AS AGENT OR AS PRINCIPAL FOR THEIR OWN ACCOUNTS AND MAY HAVE POSITIONS
OR ENGAGE IN TRANSACTIONS BASED ON OR INDEXED TO THE REUTERS/JEFFERIES CRB INDEX. IT IS POSSIBLE THAT LICENSORS’ TRADING ACTIVITY WILL AFFECT THE VALUE OF THE REUTERS/JEFFERIES CRB INDEX. LICENSORS MAY OPERATE AND MARKET OTHER INDICES THAT MAY
COMPETE WITH THE REUTERS/JEFFERIES CRB INDEX. 
  
 LICENSORS DO NOT
GUARANTEE THE QUALITY, ACCURACY AND/OR THE COMPLETENESS OF THE REUTERS/JEFFERIES CRB INDEX OR ANY DATA INCLUDED THEREIN. LICENSORS MAKE NO WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, OWNERS OF THE PRODUCT(S), OR ANY OTHER
PERSON OR ENTITY FROM THE USE OF THE REUTERS/JEFFERIES CRB INDEX OR ANY DATA INCLUDED THEREIN IN CONNECTION WITH THE RIGHTS LICENSED HEREUNDER OR FOR ANY OTHER USE. LICENSORS MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND HEREBY EXPRESSLY DISCLAIM ALL
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE REUTERS/JEFFERIES CRB INDEX OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL LICENSORS HAVE ANY LIABILITY FOR ANY
SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, LOST PROFITS), EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.” 
  
 Any changes in the foregoing disclaimers and limitations must be approved in advance in writing by an authorized officer of
each of Reuters and Jefferies. 
  
 (c) Licensee represents and
warrants to Licensors, and each Licensor represents and warrants to Licensee, that it has the authority to enter into this Agreement according to its terms. 
  
 (d) Licensee represents and warrants to Licensors that the Product(s) shall at all times comply with the descriptions in Exhibit A and shall not violate
any of the restrictions set forth therein. 
  
 (e) Licensee
represents and warrants to Licensors that the Product(s) shall not violate any applicable law, including but not limited to banking, commodities and securities laws. 
  
 (f) LICENSORS, THEIR AFFILIATES, EMPLOYEES AND AGENTS, SHALL HAVE NO LIABILITY, CONTINGENT OR OTHERWISE, TO LICENSEE OR TO
THIRD PARTIES, FOR THE ACCURACY, COMPLETENESS OR CURRENCY OF THE REUTERS/JEFFERIES CRB INDEX OR FOR DELAYS OR OMISSIONS THEREIN, OR FOR INTERRUPTIONS IN THE DELIVERY OF THE REUTERS/JEFFERIES CRB INDEX. IN NO EVENT WILL LICENSORS BE LIABLE FOR ANY
SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, LOST PROFITS) WHICH MAY BE INCURRED OR EXPERIENCED ON ACCOUNT OF LICENSEE ENTERING INTO OR RELYING ON THIS AGREEMENT, EVEN IF LICENSORS HAVE BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. WITHOUT DIMINISHING THE DISCLAIMERS AND LIMITATIONS SET FORTH IN THIS SECTION 6, IN NO EVENT SHALL THE CUMULATIVE LIABILITY OF LICENSORS TO LICENSEE UNDER THIS AGREEMENT EXCEED THE LICENSE FEES ACTUALLY
PAID TO LICENSORS HEREUNDER FOR THE FULL CALENDAR YEAR IMMEDIATELY PRECEDING THE FINDING OF SUCH LIABILITY. 
  
 (g) Licensee’s obligations under this Agreement shall be joint and several obligations of the Fund and the Managing Owner. Licensee shall indemnify,
protect, and hold harmless Licensors, their affiliates, employees and agents from and against any and all losses, liabilities, judgments, suits, actions, proceedings, claims, damages, costs (including reasonable attorneys’ fees and
disbursements) resulting from or arising out of failure to fulfill its obligations under this Agreement, the use by Licensee of the Reuters/Jefferies CRB Index, the Product(s) or otherwise arising out of this Agreement. 

 7. Confidentiality. Licensee acknowledges that it or its employees may in the course of performing their
responsibilities under this Agreement, be exposed to or acquire information which is proprietary to or confidential to Licensors or their affiliates or clients or to third parties to whom Licensors owe a duty of confidentiality. Any and all
non-public information of any form obtained by Licensee or its employees, including without limitation information related to the calculation of the Reuters/Jefferies CRB Index, shall be deemed to be confidential and proprietary information.
Licensee agrees to hold such information in confidence and not to use or disclose such information for any purpose whatsoever other than as contemplated by this Agreement and to advise each of its employees who may be exposed to such proprietary and
confidential information of their obligations hereunder. 
  
 8. No
Promotion. Except as specifically provided herein, Licensee agrees that it will not, without the prior written consent of the applicable Licensor in each instance, (i) use in advertising, publicity, or otherwise the name of a Licensor,
or any affiliate of a Licensor, or any employee of a Licensor, nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by a Licensor or its affiliates, or (ii) represent,
directly or indirectly, that any product or any service provided by Licensee has been approved or endorsed by a Licensor or Licensors. 
  
 9. Force Majeure. No party shall be liable or deemed to be in default for any delay or failure to perform under this Agreement or for interruption of the
services resulting directly or indirectly from any cause beyond such party’s reasonable control. 
  
 10. General. 
  
 (a)
Licensee acknowledges that it has not been induced to enter into this Agreement by any representation or warranty not set forth in this Agreement. This Agreement contains the entire agreement of the parties with respect to its subject matter and
supersedes all existing and all other oral, written or other communications between them concerning this subject matter. This Agreement shall not be modified in any way except by a writing signed by all parties. 
  
 (b) This Agreement may not be assigned by Licensee without the prior written
consent of Licensors. This Agreement shall be binding upon and shall inure to the benefit of the parties and their respective successors and permitted assigns. 
  

(c) If any provision of the Agreement (or any portion thereof) shall be invalid, illegal or unenforceable, the validity, legality or enforceability of
the remainder of this Agreement shall not in any way be affected or impaired thereby. 
  
 (d) All notices and other communications under this Agreement shall be (i) in writing, (ii) delivered by hand, by registered or certified mail, return receipt requested, by overnight delivery service, or by
facsimile transmission to the address set forth below or such address as a party shall specify by a written notice to the other parties and (iii) deemed given upon receipt. 
  

			
	 Notice to Reuters:
	  	Reuters America LLC
	 	  	 3 Times Square

	 	  	 New York, New York 10036

	 	  	 Attn: Thomas Gros, EVP, Global Head Equities, Commodities & EnergyFAX: 646-223-7711

		
	 Notice to Jefferies:
	  	 Jefferies Financial Products, LLC

	 	  	 The Metro Center

	 	  	 One Station Place, 3N

	 	  	 Stamford, CT 06902

	 	  	 Attn: General Counsel

	 	  	 FAX: 203-708-6529

		
	 Notice to Licensee:
	  	 Equinox Fund Management, LLC

	 	  	 1660 Lincoln Street, Suite 100

	 	  	 Denver, CO 80264

	 	  	 ATTN: [FILL IN]

	 	  	 FAX: [FILL IN]

  
 (e) The headings in
this Agreement are intended for convenience of reference and shall not affect its interpretation. 

 (f) Licensee acknowledges that a breach of any provision of Section 7 of this Agreement will cause
the applicable Licensor irreparable injury and damage and therefore may be enjoined through injunctive proceedings in addition to any other rights and remedies which may be available to Licensors at law or in equity. Licensee consents to
jurisdiction in the courts of New York for enforcement of this provision. 
  
 (g) This Agreement and all matters relating to or arising under this Agreement shall be governed in all respects by the laws of the State of New York, without giving effect to principles of conflicts of law, and any
litigation arising out of or connected in any way with this Agreement shall take place in a State or Federal court of competent jurisdiction in New York County, State of New York. 
  
 (h) The following sections shall survive termination of this Agreement: 5, 6, 7, 8 and 10. 
  
 (i) Where a Product is traded in a currency other than U.S. dollars, the U.S.
dollar equivalent, for purposes of Section 3 and Exhibit B hereunder, will be calculated using the applicable rate of exchange on the valuation date as reported in the Wall Street Journal. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day
and year first above written. 
  

									
	JEFFERIES FINANCIAL PRODUCTS, LLC	 	 	 	REUTERS AMERICA LLC
					
	 By:
	 	 	 	 	 	By:	 	 
			
	 	 	 	 	 
			
	 Name and Title
	 	 	 	 Name and Title

			
	EQUINOX FUND MANAGEMENT, LLC	 	 	 	THE FRONTIER FUND
					
	 By:
	 	 	 	 	 	By:	 	 
			
	 	 	 	 	 
			
	Name and Title	 	 	 	Name and Title

 EXHIBIT A 
  
 PRODUCTS 
  
 “Products” means: 
  

	 	•	 	Public commodity pools 

 EXHIBIT B 
  
 License Fees: 2 basis points per year, payable as follows: each calendar quarter, 0.5 basis points of (i.e., 0.00005 times) the net asset value as of the
end of such quarter of all series of the Product(s) that use, refer to, or are based on, in part or in whole, the Reuters/Jefferies CRB Index.Form of License Agreement

 EXHIBIT 10.33 
  
 LICENSE AGREEMENT 
  
 AGREEMENT dated as of                      (the
“Effective Date”) by and among JEFFERIES FINANCIAL PRODUCTS, LLC (“Jefferies” or “Licensor’), a Delaware limited liability company having an office at One Station Place, 3N, Stamford, CT 06902, The Frontier Fund (the
“Fund”), a statutory trust formed under the laws of Delaware, and Equinox Fund Management, LLC, a Delaware limited liability company with its principal office at 1660 Lincoln Street, Suite 100, Denver, CO 80264 (the “Managing
Owner”) (the Fund and the Managing Owner collectively “Licensee”). 
  
 WHEREAS, Licensor, together with affiliates or agents, as applicable, compiles, calculates, maintains and owns rights in and to the Jefferies Commodity Performance Index, and to the proprietary data contained therein
(individually and collectively referred to as the “JCPI”); and 
  
 WHEREAS, Licensee wishes to use the JCPI as the basis of the product(s) described in Exhibit A hereto (the “Product(s)”); and 
  
 WHEREAS, Licensee wishes to use Jefferies’ name and the JCPI names (together the “Marks”) in connection with
the issuance, marketing and/or promotion of the Product(s) under applicable law, rules and regulations in order to indicate that Licensor is the source of the JCPI; and 
  
 WHEREAS, Licensor wishes to license to Licensee the use of the JCPI and the Marks in connection with the Product(s) all in
accordance with the terms and conditions hereinafter set forth; 
  
 NOW, THEREFORE, the parties hereto agree as follows: 
  
 1. Grant
and Scope of License. 
  
 (a) Subject to the terms and
conditions of this Agreement, Licensor hereby grants Licensee a non-transferable, worldwide limited license, with no right to sublicense, (i) to reproduce, distribute and display publicly the JCPI, or any sub-index thereof, as a component of
the Product(s) described in Exhibits A to be issued, written and/or sold by Licensee and (ii) to use and refer to the Marks in connection with the marketing and promotion of such Product(s) and in connection with making such disclosure about
the Product(s) as Licensee deems necessary or desirable under any applicable law, rules or regulations, but, in each case, only to the extent necessary to indicate the source of the JCPI and subject to Section 4. The license granted by the
preceding sentence is exclusive for U.S. sales of the Products described in Exhibit A for the time period specified in Section 1(b) below, but is otherwise non-exclusive. It is expressly agreed and understood by Licensee that no rights to use
the JCPI or the Marks are granted hereunder other than those specifically described and expressly granted herein. 
  
 (b) The exclusivity granted in Section 1(a) of this Agreement will remain in effect for one (1) year from the Effective Date (the “First
Exclusivity Period”); provided that such exclusivity shall remain in effect (a) for up to an additional six (6) months (the “Second Exclusivity Period”) following the expiration of the First Exclusivity Period for so long as
the combined net asset value of The Frontier Fund Long Only Commodity Series-1 and The Frontier Fund Long Only Commodity Series-2 equals or exceeds $100 million at each calendar quarter end during such Second Exclusivity Period (the “$100
Million Asset Target”), and (b) for an additional six (6) months (the “Third Exclusivity Period”) following the expiration of the Second Exclusivity Period for so long as the combined net asset value of The Frontier Fund
Long Only Commodity Series-1 and The Frontier Fund Long Only Commodity Series-2 equals or exceeds $150 million at each calendar quarter end during such Third Exclusivity Period (the “$150 Million Asset Target”). Immediately upon any
failure by Licensee to meet the $100 Million Asset Target during the Second Exclusivity Period, or to meet the $150 Million Asset Target during the Third Exclusivity Period, Licensee’s rights pursuant to Section 1(a) of this Agreement
shall cease being exclusive, and Licensor, itself or through any licensee, may exercise such rights concurrently with Licensee’s exercise of such rights. 
  

(c) Licensee shall deliver to Licensor, within ten business days after each calendar month during the Term, a written report detailing, in respect of
the closing date of such month, a list of each series of Product described in Exhibit A and the net asset value of such series. 
  
 2. Term and Termination. 
  
 (a) This Agreement shall commence on the Effective Date and shall continue in effect for three (3) years (“Initial Term”), after which it
shall automatically renew for successive one-year periods (each a “Renewal Term,” collectively with the Initial Term the “Term”) unless and until (i) Licensor or Licensee terminates this Agreement at the expiration of the
Initial Term or any Renewal Term by giving at least ninety (90) days’ prior written notice to the other party, or (ii) terminated as set forth below; 

 (b) Licensor shall have the right to immediately terminate this Agreement in the event of any breach or
threatened breach of this Agreement by Licensee if: (a) the breach or threatened breach has remained uncured for thirty (3) days following Licensee’s receipt of Licensor’s written notice of such claim, or (b) the breach or
threatened breach is not susceptible to cure; and 
  
 (c) Licensor
shall have the right to terminate this Agreement if Licensor determines in its sole discretion to suspend offering the JCPI to licensees in general. 
  
 3. License Fees. 
  
 (a) Licensee shall have the right to utilize the JCPI in connection with the Product(s) listed in Exhibit A without charge as an accommodation to
Licensee. 
  
 (b) Licensee shall be responsible for all costs
associated with the receipt of the JCPI. 
  
 4. Informational Materials
Review. 
  
 (a) Licensee shall use its best efforts to
protect the goodwill and reputation of the JCPI and of the Marks in connection with its use of the Marks under this Agreement. For the avoidance of doubt, Licensee is not responsible for sending cease and desist letters and/or filing suits to
enforce the Marks; however, Licensee is responsible for notifying Licensors promptly if Licensee becomes aware of any infringement or threatened infringement. 
  

(b) Licensee shall submit to Licensor for review and approval all prospectuses, registration statements, advertisements, brochures and promotional and
any other similar informational materials (including documents required to be filed with governmental or regulatory agencies) relating to the Product(s) and that in any way use or refer to Licensor or the JCPI (the “Informational
Materials”). Licensor’s approval shall be required with respect to the use of and description of Licensor, and Licensor’s approval shall be required with respect to the use of and description of the JCPI. Approval by Licensor
hereunder shall not be unreasonably withheld or delayed. Once Informational Materials have been approved by Licensor, subsequent Informational Materials that do not alter the use or description of Licensor and the JCPI need not be submitted for
review and approval by Licensor. 
  
 5. Proprietary Rights.

  
 (a) Licensee acknowledges that the JCPI is selected,
coordinated, arranged and prepared by Licensor through the application of methods and standards of judgment used and developed through the expenditure of considerable work, time and money by Licensor. Licensee also acknowledges that, as between
Licensee and Licensor, the Marks are the exclusive property of Jefferies and/or its respective subsidiaries or affiliates, that such parties have and retain all proprietary rights therein (including, but not limited to, trademarks and copyrights)
and that the JCPI and its compilation and composition and changes therein are in the control and sole discretion of Licensor. 
  
 (b) Licensor reserves all rights with respect to the JCPI and the Marks except those expressly licensed to Licensee hereunder. 
  
 (c) The following notice will appear at the foot of any list or table which
reproduces in whole or substantial part the JCPI: “Copyright 200[ ]. Jefferies Financial Products, LLC or its affiliates. Used with permission.” 
  
 6. Warranties; Disclaimers; Indemnification. 
  
 (a) Licensor represents and warrants to Licensee that as of the date hereof Licensor or its affiliates owns all right, title and interest in, or, to the
extent not owned, have all necessary rights to use, the Marks and to grant the license hereunder. 
  
 (b) Licensee agrees expressly to be bound itself by and furthermore to include all of the following disclaimers and limitations in its Informational
Materials and any contract(s) relating to the Product(s) and upon request to furnish a copy (copies) thereof to Licensor: 
  
 “THE PRODUCT(S) IS NOT SPONSORED, ENDORSED, SOLD OR PROMOTED BY JEFFERIES FINANCIAL PRODUCTS, LLC (“JEFFERIES”) OR ANY OF ITS SUBSIDIARIES
OR AFFILIATES (COLLECTIVELY THE “LICENSOR”). LICENSOR MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO THE OWNERS OF THE PRODUCT(S) OR ANY MEMBER OF THE PUBLIC REGARDING THE ADVISABILITY OF INVESTING IN SECURITIES OR COMMODITIES
GENERALLY OR IN THE PRODUCT(S) PARTICULARLY OR THE ABILITY OF THE JCPI TO TRACK GENERAL COMMODITY MARKET PERFORMANCE. LICENSOR’S ONLY RELATIONSHIP TO [LICENSEE NAME] (“LICENSEE”) IS THE LICENSING OF THE JCPI, WHICH IS DETERMINED,
COMPOSED AND CALCULATED BY LICENSOR WITHOUT REGARD TO THE LICENSEE OR THE PRODUCT(S). LICENSOR HAS NO OBLIGATION TO TAKE THE NEEDS OF THE LICENSEE OR THE OWNERS OF THE PRODUCT(S) INTO CONSIDERATION IN DETERMINING, COMPOSING OR CALCULATING THE JCPI.
LICENSOR IS NOT RESPONSIBLE FOR AND HAS NOT PARTICIPATED IN THE 

 
DETERMINATION OF THE TIMING OF, PRICES AT, OR QUANTITIES OF THE PRODUCT(S) TO BE ISSUED OR IN THE DETERMINATION OR CALCULATION OF THE EQUATION BY WHICH THE
PRODUCT(S) IS TO BE CONVERTED INTO CASH. LICENSOR HAS NO OBLIGATION OR LIABILITY IN CONNECTION WITH THE ADMINISTRATION, MARKETING OR TRADING OF THE PRODUCT(S). 
  

LICENSOR AND ITS AFFILIATES AND THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES AND AGENTS MAY BUY OR SELL SECURITIES OR COMMODITIES MENTIONED OR
CONTEMPLATED HEREIN AS AGENT OR AS PRINCIPAL FOR THEIR OWN ACCOUNTS AND MAY HAVE POSITIONS OR ENGAGE IN TRANSACTIONS BASED ON OR INDEXED TO THE JCPI. IT IS POSSIBLE THAT LICENSOR’S TRADING ACTIVITY WILL AFFECT THE VALUE OF THE JCPI. LICENSOR
MAY OPERATE AND MARKET OTHER INDICES THAT MAY COMPETE WITH THE JCPI. 
  
 LICENSOR DOES NOT GUARANTEE THE QUALITY, ACCURACY AND/OR COMPLETENESS OF THE JCPI OR ANY DATA INCLUDED THEREIN. LICENSOR MAKES NO WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, OWNERS OF THE PRODUCT(S), OR ANY OTHER
PERSON OR ENTITY FROM THE USE OF THE JCPI OR ANY DATA INCLUDED THEREIN IN CONNECTION WITH THE RIGHTS LICENSED HEREUNDER OR FOR ANY OTHER USE. LICENSOR MAKES NO EXPRESS OR IMPLIED WARRANTIES, AND HEREBY EXPRESSLY DISCLAIMS ALL WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE JCPI OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL LICENSOR HAVE ANY LIABILITY FOR ANY SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR
CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, LOST PROFITS), EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.” 
  
 Any changes in the foregoing disclaimers and limitations must be approved in advance in writing by an authorized officer of Jefferies. 
  
 (c) Licensee represents and warrants to Licensor, and Licensor represents and
warrants to Licensee, that it has the authority to enter into this Agreement according to its terms. 
  
 (d) Licensee represents and warrants to Licensor that the Product(s) shall at all times comply with the relevant description in Exhibit A and shall not
violate any of the restrictions set forth therein. 
  
 (e)
Licensee represents and warrants to Licensor that the Product(s) shall not violate any applicable law, including but not limited to banking, commodities and securities laws. 
  
 (f) LICENSOR, ITS AFFILIATES, EMPLOYEES AND AGENTS, SHALL HAVE NO LIABILITY, CONTINGENT OR OTHERWISE, TO LICENSEE OR TO
THIRD PARTIES, FOR THE ACCURACY, COMPLETENESS OR CURRENCY OF THE JCPI OR FOR DELAYS OR OMISSIONS THEREIN, OR FOR INTERRUPTIONS IN THE DELIVERY OF THE JCPI. IN NO EVENT WILL LICENSOR BE LIABLE FOR ANY SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR
CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, LOST PROFITS) WHICH MAY BE INCURRED OR EXPERIENCED ON ACCOUNT OF LICENSEE ENTERING INTO OR RELYING ON THIS AGREEMENT, EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. WITHOUT
DIMINISHING THE DISCLAIMERS AND LIMITATIONS SET FORTH IN THIS SECTION 6, IN NO EVENT SHALL THE CUMULATIVE LIABILITY OF LICENSOR TO LICENSEE UNDER THIS AGREEMENT EXCEED THE LICENSE FEES ACTUALLY PAID TO LICENSOR HEREUNDER FOR THE FULL CALENDAR YEAR
IMMEDIATELY PRECEDING THE FINDING OF SUCH LIABILITY. 
  
 (g)
Licensee’s obligations under this Agreement shall be joint and several obligations of the Fund and the Managing Owner. Licensee shall indemnify, protect, and hold harmless Licensor, its affiliates, employees and agents from and against any and
all losses, liabilities, judgments, suits, actions, proceedings, claims, damages, costs (including reasonable attorneys’ fees and disbursements) resulting from or arising out of failure to fulfill its obligations under this Agreement, the use
by Licensee of the JCPI, the Product(s) or otherwise arising out of this Agreement. 
  
 7. Confidentiality. Licensee acknowledges that it or its employees may in the course of performing their responsibilities under this Agreement, be exposed to or acquire information which is proprietary to or confidential to
Licensor or its affiliates or clients or to third parties to whom Licensor owes a duty of confidentiality. Any and all non-public information of any form obtained by Licensee or its employees, including without limitation information related to the
calculation of the JCPI, shall be deemed to be confidential and proprietary information. Licensee agrees (a) to hold such information in confidence and not to use or disclose such information for any purpose whatsoever other than as
contemplated by this Agreement, (b) to ensure that its employees and agents gain access to such information only if they owe a duty of confidentiality to Licensee, only as necessary to effectuate or perform under this Agreement, and only after
Licensee has informed each of such employees or agents who may be exposed to such proprietary and confidential information of their obligations hereunder. Licensee will promptly notify Licensor of any unauthorized release or use of such information.

 8. No Promotion. Except as specifically provided herein, Licensee agrees that it will not, without the
prior written consent of Licensor in each instance, (i) use in advertising, publicity, or otherwise the name of Licensor, or any affiliate of Licensor, or any employee of Licensor, nor any trade name, trademark, trade device, service mark,
symbol or any abbreviation, contraction or simulation thereof owned by Licensor or its affiliates, or (ii) represent, directly or indirectly, that any product or any service provided by Licensee has been approved or endorsed by Licensor.

  
 9. Force Majeure. No party shall be liable or deemed to be in
default for any delay or failure to perform under this Agreement or for interruption of the services resulting directly or indirectly from any cause beyond such party’s reasonable control. 
  
 10. General. 
  
 (a) Licensee acknowledges that it has not been induced to enter into this Agreement by any representation or warranty not
set forth in this Agreement. This Agreement contains the entire agreement of the parties with respect to its subject matter and supersedes all existing and all other oral, written or other communications between them concerning this subject matter.
This Agreement shall not be modified in any way except by a writing signed by all parties. 
  
 (b) This Agreement may not be assigned by Licensee without the prior written consent of Licensor. This Agreement shall be binding upon and shall inure to the benefit of the parties and their respective successors and
permitted assigns. 
  
 (c) If any provision of the Agreement (or
any portion thereof) shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remainder of this Agreement shall not in any way be affected or impaired thereby. 
  
 (d) All notices and other communications under this Agreement shall be
(i) in writing, (ii) delivered by hand, by registered or certified mail, return receipt requested, by overnight delivery service, or by facsimile transmission to the address set forth below or such address as a party shall specify by a
written notice to the other party and (iii) deemed given upon receipt. 
  

			
	 Notice to Licensee:
	  	Equinox Fund Management, LLC
	 	  	1660 Lincoln Street, Suite 100
	 	  	Denver, CO 80264
	 	  	ATTN: [FILL IN]
	 	  	FAX: [FILL IN]
		
	 Notice to Licensor:
	  	Jefferies Financial Products, LLC
	 	  	The Metro Center
	 	  	One Station Place, 3N
	 	  	Stamford, CT 06902
	 	  	Attn: General Counsel
	 	  	FAX: 203-708-6529

  
 (e) The headings in
this Agreement are intended for convenience of reference and shall not affect its interpretation. 
  
 (f) Licensee acknowledges that a breach of any provision of Section 7 of this Agreement will cause Licensor irreparable injury and damage and
therefore may be enjoined through injunctive proceedings in addition to any other rights and remedies which may be available to Licensor at law or in equity. Licensee consents to jurisdiction in the courts of New York for enforcement of this
provision. 
  
 (g) This Agreement and all matters relating to or
arising under this Agreement shall be governed in all respects by the laws of the State of New York, without giving effect to principles of conflicts of law, and any litigation arising out of or connected in any way with this Agreement shall take
place in a State or Federal court of competent jurisdiction in New York County, State of New York. 
  
 (h) The following sections shall survive termination of this Agreement: 5, 6, 7, 8 and 10. 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

  

									
	JEFFERIES FINANCIAL PRODUCTS, LLC	 	 	 	THE FRONTIER FUND
					
	 By:
	 	 	 	 	 	 By:
	 	 
			
	 	 	 	 	 
	Name and Title	 	 	 	Name and Title

  

			
	EQUINOX FUND MANAGEMENT, LLC
		
	 By:
	 	 
	
	 
	Name and Title

 EXHIBIT A 
  
 PRODUCTS 
  
 “Products” means: 
  

	 	•	 	Public commodity pools

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}]]